Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

57.54
-0.7900-1.35%
Volume:698.04K
Turnover:40.33M
Market Cap:14.26B
PE:18.09
High:58.33
Open:58.33
Low:57.45
Close:58.33
52wk High:59.72
52wk Low:33.76
Shares:247.78M
Float Shares:214.00M
Volume Ratio:0.35
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.18
EPS(LYR):2.78
ROE:44.39%
ROA:23.97%
PB:7.73
PE(LYR):20.70

Loading ...

Exelixis director Mary C. Beckerle disposes 7,712 shares for $373,646.4

Reuters
·
May 09

Exelixis Director Maria C. Freire disposes 20,634 shares for $949,164

Reuters
·
May 09

Exelixis director George Poste disposes 60,000 shares for $2.74 million

Reuters
·
May 09

Exelixis to webcast investor conference fireside chats in May

Reuters
·
May 08

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

Exelixis (EXEL) Margin Expansion To 35.1% Challenges Bearish Pricing Narratives

Simply Wall St.
·
May 07

Exelixis, Inc. : H.c. Wainwright Raises Target Price to $56 From $54

THOMSON REUTERS
·
May 07

Exelixis price target raised to $50 from $49 at Morgan Stanley

TIPRANKS
·
May 07

Exelixis price target raised to $47 from $44 at Stifel

TIPRANKS
·
May 07

Stock Track | Exelixis Soars 9.32% Intraday on Analyst Upgrades and Strong Q1 Earnings

Stock Track
·
May 07

Exelixis Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 07

Exelixis Seen Trading Steady on Modest Drug Growth, RBC Says

MT Newswires Live
·
May 07

Stock Track | Exelixis Soars 5.99% in Pre-market on Analyst Upgrades and Strong Q1 Earnings

Stock Track
·
May 06

Goldman Sachs Remains a Buy on Exelixis (EXEL)

TIPRANKS
·
May 06

Exelixis (EXEL) Gets a Hold from Wells Fargo

TIPRANKS
·
May 06

Exelixis Kept at Hold as Cabo Momentum Offsets Pipeline Uncertainty; Price Target Raised from $49 to $50

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)

TIPRANKS
·
May 06

Margin Gains From Oncology Portfolio Might Change The Case For Investing In Exelixis (EXEL)

Simply Wall St.
·
May 06

Exelixis Price Target Raised to $55 on Cabo Strength, Buyback-Driven EPS Growth, and Zanzalintinib Upside Optionality

TIPRANKS
·
May 06

Exelixis Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06